AR064104A1 - Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas - Google Patents
Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlasInfo
- Publication number
- AR064104A1 AR064104A1 ARP070105388A ARP070105388A AR064104A1 AR 064104 A1 AR064104 A1 AR 064104A1 AR P070105388 A ARP070105388 A AR P070105388A AR P070105388 A ARP070105388 A AR P070105388A AR 064104 A1 AR064104 A1 AR 064104A1
- Authority
- AR
- Argentina
- Prior art keywords
- valsartan
- microemulsion
- prepare
- methods
- dosage forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Abstract
Un sistema de suministro de fármaco, por ejemplo un pre-concentrado en microemulsion, que forma espontáneamente una microemulsion cuando se pone en contacto con un medio acuoso. El sistema de suministro de fármaco contiene valsartan, un componente hidrofílico, un componente lipofílico, y un tensoactivo. Un componente hidrofílico particularmente util en el sistema es un polímero que es solido a temperatura ambiente, por ejemplo PEG solido. Reivindicacion 1: Una composicion farmacéutica, la cual comprende: (a) valsartan; y (b) un tensoactivo, un componente lipofílico, y un componente hidrofílico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86860406P | 2006-12-05 | 2006-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR064104A1 true AR064104A1 (es) | 2009-03-11 |
Family
ID=39365945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070105388A AR064104A1 (es) | 2006-12-05 | 2007-12-03 | Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas |
Country Status (15)
Country | Link |
---|---|
US (1) | US20100035949A1 (es) |
EP (1) | EP2111217A2 (es) |
JP (1) | JP2010511722A (es) |
KR (1) | KR20090086281A (es) |
CN (1) | CN101541306A (es) |
AR (1) | AR064104A1 (es) |
AU (1) | AU2007333355B2 (es) |
BR (1) | BRPI0720077A2 (es) |
CA (1) | CA2671495A1 (es) |
CL (1) | CL2007003484A1 (es) |
MX (1) | MX2009005947A (es) |
PE (1) | PE20081443A1 (es) |
RU (1) | RU2009125613A (es) |
TW (1) | TW200840596A (es) |
WO (1) | WO2008073731A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013512948A (ja) * | 2009-12-08 | 2013-04-18 | イル・ファ・カンパニー・リミテッド | 20−O−β−D−グルコピラノシル−20(S)−プロトパナキサジオールを含む固体分散体 |
WO2014009434A1 (en) | 2012-07-11 | 2014-01-16 | Sandoz Ag | Self-microemulsifying drug delivery system of abiraterone or abiraterone acetate |
WO2017096427A1 (en) | 2015-12-09 | 2017-06-15 | Phosphagenics Limited | Pharmaceutical formulation |
RU2742650C2 (ru) * | 2015-12-09 | 2021-02-09 | Фосфейдженикс Лимитед | Фармацевтический состав |
CN110662733A (zh) | 2016-12-21 | 2020-01-07 | 埃维科生物技术有限公司 | 方法 |
KR101920628B1 (ko) * | 2017-04-12 | 2018-11-22 | 대원제약주식회사 | 안지오텐신 수용체 길항제를 포함하는 약제학적 조성물 |
CN111183991A (zh) * | 2020-03-03 | 2020-05-22 | 安徽金敦福农业科技有限公司 | 一种含有百里香酚的农药组合物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
US20020102301A1 (en) * | 2000-01-13 | 2002-08-01 | Joseph Schwarz | Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof |
US20020132839A1 (en) * | 2000-06-22 | 2002-09-19 | Ganter Sabina Maria | Tablet formulations comprising valsartan |
BRPI0518239A2 (pt) * | 2004-10-29 | 2008-11-11 | Novartis Ag | composiÇÕes farmacÊuticas espontaneamente dispersÍveis |
MX2007012947A (es) * | 2005-04-18 | 2008-04-09 | Rubicon Res Pvt Ltd | Composiciones biomejoradas. |
-
2007
- 2007-12-03 JP JP2009540402A patent/JP2010511722A/ja not_active Withdrawn
- 2007-12-03 BR BRPI0720077-3A2A patent/BRPI0720077A2/pt not_active IP Right Cessation
- 2007-12-03 CA CA002671495A patent/CA2671495A1/en not_active Abandoned
- 2007-12-03 AR ARP070105388A patent/AR064104A1/es unknown
- 2007-12-03 RU RU2009125613/15A patent/RU2009125613A/ru not_active Application Discontinuation
- 2007-12-03 KR KR1020097013926A patent/KR20090086281A/ko not_active Application Discontinuation
- 2007-12-03 US US12/517,105 patent/US20100035949A1/en not_active Abandoned
- 2007-12-03 EP EP07871651A patent/EP2111217A2/en not_active Withdrawn
- 2007-12-03 AU AU2007333355A patent/AU2007333355B2/en not_active Expired - Fee Related
- 2007-12-03 CN CNA2007800441500A patent/CN101541306A/zh active Pending
- 2007-12-03 PE PE2007001702A patent/PE20081443A1/es not_active Application Discontinuation
- 2007-12-03 WO PCT/US2007/086226 patent/WO2008073731A2/en active Application Filing
- 2007-12-03 MX MX2009005947A patent/MX2009005947A/es not_active Application Discontinuation
- 2007-12-04 CL CL200703484A patent/CL2007003484A1/es unknown
- 2007-12-04 TW TW096146195A patent/TW200840596A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CL2007003484A1 (es) | 2008-07-11 |
AU2007333355B2 (en) | 2011-10-20 |
WO2008073731A2 (en) | 2008-06-19 |
RU2009125613A (ru) | 2011-01-20 |
MX2009005947A (es) | 2009-06-17 |
BRPI0720077A2 (pt) | 2013-12-24 |
TW200840596A (en) | 2008-10-16 |
US20100035949A1 (en) | 2010-02-11 |
WO2008073731A3 (en) | 2009-03-19 |
CN101541306A (zh) | 2009-09-23 |
AU2007333355A1 (en) | 2008-06-19 |
CA2671495A1 (en) | 2008-06-19 |
KR20090086281A (ko) | 2009-08-11 |
JP2010511722A (ja) | 2010-04-15 |
EP2111217A2 (en) | 2009-10-28 |
PE20081443A1 (es) | 2008-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR064104A1 (es) | Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas | |
CL2009002073A1 (es) | Composicion farmaceutica solida para la liberacion controlada de un agente activo activo en el tracto gastrointestinal que comprende al menos un agente acido con solubilidad de menos de 0,3 mg/ml en solucion acuosa a un ph alrededor del pka del agente acido, un polimero hidrofilo, un alcanizador; uso en trastornos cardiovasculares. | |
CY1120377T1 (el) | Στερεη φαρμακευτικη δοσολογικη φαρμακοτεχνικη μορφη που περιεχει λοπιναβιρη | |
CL2007002649A1 (es) | Composicion farmaceutica que comprende 2-[6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil]-4-fluoro-benzonitrilo; y uso para el tratamiento de la diabetes. | |
BRPI0714399B8 (pt) | composição farmacêutica líquida oral | |
CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
WO2008129106A3 (es) | Nanopartículas que comprenden una ciclodextrina y una molécula biológicamente activa y sus aplicaciones | |
CL2007002594A1 (es) | Compuestos derivados de piridin-3-il, agentes inmunomoduladores; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de enfermedades asociadas con un sistema inmunologico activado. . | |
CR20110110A (es) | Composicion farmaceutica | |
WO2008128775A3 (en) | Stabilised pharmaceutical composition containing pregabaline | |
WO2007146227A3 (en) | Flow-induced delivery from a drug mass | |
CL2009001080A1 (es) | Procedimiento para encapsular agentes biologicamente activos en un vehiculo en forma de particulas, que comprende solubilizar en un agente de apareamiento de ion hidrofobo y un disolvente, disolver, formar la emulsion y obtener el vehiculo; vehiculo en forma de particulas; y composicion farmaceutica que comprende el vehiculo. | |
CO6280466A2 (es) | Forma de dosificacion farmaceutica de liberacion controlada | |
AR060016A1 (es) | Sistema de liberacion de plaguicida | |
BRPI0922435A2 (pt) | "composto de tiazolopiridina moduladores de sirtuina, composição farmacêutica compreendendo o mesmo e seu uso." | |
ECSP109852A (es) | Uso de homo y copolímeros para la estabilización de formulaciones de principios activos | |
BR112015021002A2 (pt) | forma de dosagem sólida restringente de abuso para liberação imediata com entalhe funcional | |
WO2009032481A3 (en) | Stable emulsion formulation hindering interaction across the water-oil interface | |
BRPI0908097A2 (pt) | uso de pelo menos um composto, peptídeo, e, formulação farmacêutica. | |
PE20070377A1 (es) | Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol | |
GT200800115A (es) | Metodos para tratar infecciones del tracto gastrointestinal con tigeciclina | |
BRPI0610690A2 (pt) | processo para a produção de uma solução polimérica aquosa, uso da solução polimérica aquosa, e dispositivo para a dissolução de pó / líquido de polímero solúvel em água interligados condutivamente | |
AR071568A1 (es) | Composicion de suspension pesticida acuosa | |
GT201000102A (es) | Producto de dispersión sólida de drogas basadas en n-aril urea | |
BR112012006056A2 (pt) | forma de dosagem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |